biotech

A few months ago we saw the biotechs showing relative strength as can be seen by the rising ratio line from May going into June. What followed was an explosive rally in July. You'll notice in the above chart that the MACD triggered a buy signal in early July which turned out to be quite profitable. I believe we are seeing the same pattern take place right now. In the above chart of XBI (

Análisis tecnico Puleva Biotech. Pulsa en los gráficos para verlos en alta resolución. Antes de entrar a hablar de Puleva BIO, quiero recomendaros que veais la figura que esta formando Zeltia, es un tringulo expansivo, una figura poco habitual en los graficos, teneis el dibujo en nuestro foro de Zeltia, foro que por supuesto cuenta con mucha mas informacion sobre este valor en sus mas de 120

The global food crisis has many causes. However, according to the biotechnology industry, there’s a simple solution: genetically modified crops. Biotech multinationals have touted miracle crops that will supposedly increase yields, tolerate droughts, and grow in saline soils. But not everyone is convinced. In fact, the UN and World Bank recently completed an broad scientific assessment of world

Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company’s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.They have 34 products in their product portfolio which co

Incorporated in 1995, Chemcel Biotech Limited is in the business of manufacturing of Agro Chemicals. Company’s main products are in three forms i.e. liquids, granules and dusts. Chemcel Biotech has CIB registrations for 34 products to manufacture pesticides for crops i.e. Paddy, Cotton, Sugarcane, Turmeric, Chillies, Pulses, Vegetable etc.They have certificate of registrations for 34 formulation

The second largest city in the Czech Republic is hoping to capitalize on its skilled workforce and partnership with the United States’ Mayo Clinic by becoming a European biotechnology hub. The research center that is based in Rochester, Minnesota is known around the globe for treating rare diseases and some of the biggest names in the world, as well as performing research. It is the first tim

Chemcel Biotech Limited, manufacturer of Agro Chemicals products, is coming out with an IPO of 1,54,00,000 equity shares of face value Rs. 10 at an issue price of Rs. 16. The IPO will be launched on... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Hi ThereA good news for those who still counting on biotech ..There s a company shortly openin .. in the year ending.Company's name is disclosed due to marketing stratgies anyways.Requirement: A very sound pratical knoweldge in the field of biotech is a must.Qualification: post graduates..Experience >1 year .. (added advantage)(additonal diplomas or any related on job traning courses will be an ad

Free Intraday Tips for 29th July 08STERLINBIO ( Sterling Biotech Limited ) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE220215224230S.SELL BELOW213217209200Click here for recommendations of stocks below Rs.150NMDC ( NMDC Limited ) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE285280289294S.SELL BELOW278282275265PUNJLLOYD ( Punj Lloyd Limited ) ActionTrigger Price Stop LossTar

By Dr. Steve SjuggerudIf you catch just one biotech bull market, you'll never have to work again.I've said that many times. The average biotech bull market has been good for 566% gains in less than three years.At the moment, biotech is looking incredibly bullish right now. Yesterday was the turning point...Yesterday, shares of biotech giant Genentech shot up 13% as big pharmaceutical company Roche

Capitalizing in the Biotech IndustryAction Biotech believes in the substantial future potential of stem cell treatments for many serious health conditions. They are venture capitalists who invest strategically in small companies that have promising stem cell capabilities.Some of the Californian stem cell companies in which they have invested are beginning to show promising results in fields such a

Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the U.S. is expected to post $0.86 EPS on $3.23... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Análisis tecnico Puleva Biotech. Pulsa en los gráficos para verlos en alta resolución. Aqui tenemos otro ejemplo de que las figuras bajistas se cumplen en nuestro mercado, sobre todo en el caso de los small caps. Como veis en el grafico Puleva Bio definio un triangulo en Noviembre - Abril con un objetivo bajista tras la ruptura en 1,40 euros, hacia donde se ha dirigido el valor como "alma

Free Intraday Tips for 27th June 08STERLINBIO ( Sterling Biotech Limited ) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE193186200206S.SELL BELOW185188180167Click here for recommendations of stocks below Rs.150TATACHEM ( Tata Chemicals Ltd ) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE316311324335S.SELL BELOW308313301285PSTL ( Pyramid Saimira Theatre Limited ) ActionTrigger

The Nthrys Biotech Labs in Hyderabad has launched Nthrys bioinfo labs and they are offering "Minor and Major Project" training for B,sc, M.Sc, B.Tech, M.Tech bioinformatics , Biotechnology students and other interested candidates.Now the next batch admission going on and the project fees structure starting 3800 onwards .FOR MORE INFORMATION:The Nthrys biotech LabsHyderabadMobile : 9849854748Mail :

Out of the daily movers this last week, many of the top winners and losers were from news in many of the smaller biotech stocks. We prepared a list of the... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Comentario del IBEX 35: será por el comentario de Trichet, será por apatía, será por desconfianza, por lo que Ud. quiera, el caso es que aun no se han descontado todas las noticias negativas y a la mínima nos damos el batacazo. El selectivo finalizó, tras recortar un 0,76% en los 13.239 puntos, cotizó durante algunos momentos sobre los 13.400 puntos pero esta cota parece ir tomando fuerza c

El otro día comentamos sobre los nuevos botes inflables motorizados, una opción a tener en cuenta en materia de entretenimiento para este verano. Pero si deseas algo más sencillo y  relajante, el nuevo Deluxe BioTech Spa, es lo que buscas. Básicamente se trata de una pileta inflable con capacidad para cuatro adultos que te brindara un [...]

Name: swatiQ: What are the career options after bsc biotech? Are there enouh placements for biotech in delhi?  What about Amity?

Name: Aakash MehtaQ: I have just passed my S.S.C exams.I want to pursue Biotech after H.S.C.Is it necessary to give MHT-CET after finishing HSC.

Baltimore — (TFN): The development of cutting-edge biologic drugs that are already improving – even saving – lives marks Osiris Therapeutics as a winner among biotech stocks. Their multi-purpose wonder-drug Prochymal is set to be the first FDA approved stem cell therapy. Watch the video. ****Make sure you sign up for our FREE TFN [...]

A Today’s Financial News Research Report: ‘This Maryland-based biotechnology firm develops treatments for conditions as varied as Crohn’s disease, knee arthritis, tissue damage, life-threatening Graft-versus-host disease and acute radiation syndrome.’ – Laura Cadden By Laura Cadden, TodaysFinancialNews.com Today’s Financial News feed provides an indepe

Came across these interesting articles equating bio-technology with black magick and alchemy.One could say that the current food crisis resulting from biotechnology applied to mass production of foods as well as their commodification into bio-fuels is an act of black magick.Fulfilling the prediction made by Shulamith Firestone back in the seventies when she did her feminist critique of reproductiv

It's Biotech's Year: 'Eight Great' Business Plans Aim to Help People Live Longer and BetterA decade ago, when the Wharton Business Plan Competition (BPC) began, the Internet dominated discussions about entrepreneurship. That was before the bubble burst and many dot.coms were revealed to be, in the words of New Yorker writer John Cassidy, little more than dot.cons. These days, the new arena of inte

AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

In attempt to compete with more equal footing in the biotech market, Malaysian banks are offering finance loans to companies in this sector. It is hoped that a greater availability of finance loans will help new companies get started and help bring more money into Malaysia and more jobs. Although the biotech market is very [...]

Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a company update and clinical trial... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Name: ravitejaQ: Sir i had completed my 2B.Sc bio-che.i wanna do M.Sc  in IIT .and here my question is which subject should i take-(bioche Or biotech Or micro)to grow my future well in india.please inform immediatly as possible as i have to take coaching basing on ur suggestion.

There are lots of names moving in biotech and related fields today, and below are some of the top movers: Anika Therapeutics Inc. (NASDAQ: ANIK) moving up... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Generex Biotechnology Company (NASDAQ: GNBT), a drug delivery system and technology developer, has filed an offering by selling stockholders of up to... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. Here were the big movers:... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

España, Madrid - Dos investigadores de la Escuela Técnica Superior de Ingenieros Agrónomos de la Universidad Politécnica de Madrid (UPM), Antonio Molina y Pablo Rodríguez acaban de crear la empresa ‘Plant Response Biotech’ para dar respuesta a las necesidades técnicas y científicas del sector agroalimentario, biotecnológico y bioenergético, según informó hoy la Universidad. El equipo de ‘Plant [...]

Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Amylin Pharmaceuticals (NASDAQ: AMLN) reported first quarter losses of $68.8 million, or $0.51 EPS, wider than the $49.4 million in the first quarter of 2007.... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Promising career prospect in biotechnology industry in Malaysia may be hampered by low and uncompetitive salary package. In late 2006, the International Herald Tribune reported some trend of Malaysian researchers migrating to the neighboring country Singapore for better environment and salary package. The report, which also gave indication that as much as 60% of Singapore’s biotechnology researchers [...]

If you thought biotech news was getting quiet going into earnings season, think again. Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug,... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

The $8.8 Billion cash buyout of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) has created a situation worth monitoring today. It isn't just that this buyout... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are $0.82 EPS on $3.11 billion in revenues.... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

AspenBio Pharma (NASDAQ: APPY) entered into a definitive agreement with Novartis Animal Health for AspenBio’s recombinant single-chain bovine products for... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Panacea Biotech is predominantly recognized as the company that manufactures the polio vaccines in India. And recently the stock price saw a major spurt when the Union Budget announced that there would be increased allocation for polio and this company is to be one of the major beneficiaries. The future might be good but the same cannot be said about its Q3 performance. The financial performance

CombinatoRx, Incorporated (NASDAQ: CRXX) up 8% to $3.45 on no recent developments. The 52-week range is $3.11 to $7.37. Yesterday, the company hit a 52-week... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Romania, which has until now been one of the most receptive European markets for genetically modified crops, is moving toward a reversal of its stance. Romania's environment minister Attila Korodi said that he would ask a committee of experts to revaluate MON810, a gene-altered version of corn which is the only modified crop that has been approved for commercial planting in the European Union. Korodi said that not enough studies had been done to gauge the effects of the corn on ecological systems in Romania, and that banning biotech crops could increase rural prosperity by allowing farmers to take advantage of a growing global demand for organic food.

Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

It seems that Scientists will be serving up leaner beef, tastier cheddar and healthier ketchup. Just ask Rena Marie Pacella over at Popular Science. According to her, if the biotech industry has it's way, ordering hamburger might soon sound something like this: "one charbroiled cloned-beef patty, with genetically modified cheese, lab-grown bacon and vitamin-C-fortified lettuce, on a protein-spiked bun." Basically, the burger of the future is delicious, nutritious and contains more engineering than a stealth bomber. With the Food and Drug Administration ruling in January that meat and milk from cloned cows, pigs, goats and their offspring is safe to eat, the only thing keeping the superburger off your dinner plate is time. Hey, I'm a pro-science gal .. but in this case it seems to me tha

EPIX Pharmaceuticals, Inc. (EPIX) has seen shares essentially chopped in half today. Early this morning the company announced that it was discontinuing its... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Amicus Therapeutics (NASDAQ: FOLD) had a late afternoon surge, up 7% to $10.73. The 52 week range is $9.00 to $18.22. Baxter International (NYSE:... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Biotech’s are sliding along with all the others today. A look at the highlights and outliers: Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Genentech Inc. Chairman and Chief Executive Arthur Levinson collected compensation valued at $13.9 million in 2007 as the biotechnology giant watched its share prices fall amid slowing growth in sales of its cancer-fighting drugs.According to a proxy statement the company filed Wednesday with the Securities and Exchange Commission, Levinson received just under $1 million in [...]

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) may have just joined the ranks of a biotech zombie, even if it doesn't want to admit that. The company announced... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Comentario del IBEX 35: jornada de recorte para el IBEX que pese a todo sigue por encima de los 12.700 puntos, en un rango cada vez más estrecho del que saldrá en próximas sesiones. Hoy destacaron los fuertes recortes de Ferrovial (-4,2%) presionado por malas noticias y por la tendencia claramente bajista que parece empujar la cotización hacia los 37,90 €; Inditex (-3,7%); y Mapfre (-3,5%) presionada por la tendencia que la puede arrastrar nuevamente hacia los entornos de 2,50 - 2,60 €. Los ganadores han sido Iberia (+1,8%) que tras los fuertes recortes que acumula parece haber encontrado soporte en 2,20 €; Criteria (+1,7%) atentos al soporte en 4 €; y Grifols (+1,6%) que de momento conserva los 15 € aunque tiene resistencia clara en 17 €.Solaria: demasiada volatilidad. Hoy

Biotechnology is not all about white coated doctors hovering around petri-dishes and microscopes, finding out ways to make medicines and drugs better. The field of biotechnology is much more than that and holds immense career growth potential for a student.The "biological revolution' has led to a diversification in the field of biotechnology, encompassing an extensive choice of careers. Knowledge of biology, chemistry and other life sciences is necessary for a student to venture into this field.Biotech students can put their knowledge to use in agriculture, biology, medicine, genetics and education, livestock production, environmental protection, veterinary medicine, plant science, forensics, energy production and even in corporate laboratories.For students interested in biotechnology but without extensive expertise there are regulatory and authorizer positions which they can take up. A student can pursue a job in sales and marketing where intensive knowledge of biological processe

A study sponsored by the drug industry found that life science companies account for a diminutive, but growing part of the state’s economy. The study highlights the multiplier effect in the current pharmaceutical industry. For every job that it generates, an additional five jobs are created in another industry.A career in the biopharmaceutical field can be very lucrative as biotech organizations and drug corporations compensate generously. There is a wide selection of jobs that are available for the picking. A student could be a biostatistician, a chemist, or even a clinical programmer.Drug safety specialists, microbiologists, pathologists and toxicologists are some of the higher paying jobs in this field. A student can also apply for a job in the writing field as a technical or medical writer. The opportunities are endless and the best of the biopharm companies are hiring in numbers.The National Institute of Science Media under the helm of Joel Ball, the President, publishes career

Dan Pritch of Everyday Finance started digging around two biotech stocks, Clinical Data (CLDA) and HALOZYME THERAPEUTIC (HALO) after reading an article in BusinessWeek and found that they both have enormous potential. RJ Kirk (billionaire biotech investor)owns 40% of Clinical Data. Kirk has shown a penchant for pursuing the right deals and having his companies taken out for premiums following their already impressive ascent. They also have an antidepressant in Phase 3 and given the relatively weak pipelines of big pharma/biotech these da

We saw some interesting movement in a few names today, and thought we'd suggest some possible ways to trade them. Click through to see option trade ideas for: Celgene (CELG) Biogen (BIIB) Microsoft (MSFT) Apple (AAPL) and be sure to let us know if you make bank from our free picks!

Genentech Inc. (NYSE:DNA) is set to report earnings after today's close. First Call has consensus... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

How awesome would it be to have a clone? You might be tempted to think that I’d get a little more writing done if I had one, but if anything, I’d probably be writing less. Hell, I’m pretty hard-up for good conversation around these parts (what with neighbours obsessed with kicking and rapping, stealing medication from the Elderly and rooting their cats), so chances are I’d spend most of my time getting drunk and watching re-runs of King of the Hill with my clone. Sure, it’d be fun for the first few days, until the money and the beer ran out. I’m a thirsty motherfucker at the best of times, so I’d imagine my clone (Jon 2.0) would be doubly so. Sooner or later, we’d be bound to get into a fight about something and quite frankly, I’m so out of shape that I’m not sure if I could kick my own ass, should the need arise. One good nipple-cripple and I’d be a dead man. Cloning also raises another issue (and I’d imagine you saw this one coming a mile away)… if you ha

Analisis y graficos de Puleva Biotech a 28 de Septiembre de 2007. Pincha en la imagen para ver el grafico ampliado. ¡Que peligro! esto es lo primero que he pensado tras la subida de hoy, ojo que yo no digo que en este caso el rumor de Opa sea falso ni cierto porque no lo se, pero en el 90-95% de las ocasiones este tipo de rumores son falsos, y normalmente surgen de los mismos que pueden haber

On today's STOP TRADING segment on CNBC, Jim Cramer discussed Freddie Mac (NYSE:FRE) and Fannie Mae... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Which is more important - Biotech or IT? Do we show it by our investments? Do we encourage one over the other by legislation? If there were two stories, two competing headlines, one for the new iPhone and one for the recent advance in diabetes research, which do you read? Which is more important for our future? Perhaps most people consider it sufficient to read about pharmaceuticals in the context of which celebutart (Lindsey Lohan, Paris Hilton, or Nichole Ritchie) has been arrested this week.I was intrigued by Guy Kawasaki's interview with Moira Gunn that he posted yesterday. I'm not sure I care for the title. I think that it might hurt her ability to be taken seriously but that is between Moira and Guy I suppose.My thoughts were piqued by one of the questions he asked? "Just how pervasive is biotech in our everyday lives?" I imagine that very few people realize how pervasive it is. Her answer was very enlightening. (the link above will take you there. I'm not s

Information provided by Oil Offshore Marine Online Library Series, and posted here, on Oil Offshore Marine Blog Biotech Oil Nigeria Ltd Any email or other communication (by telephone, fax or other form) originating from Biotech Oil Nigeria Ltd, www.biotechoilng.net, info@biotechoilng.net, recruitment@biotechoilng.net, or career@biotechoil.net MUST NOT be trusted, as Biotech Oil Nigeria are proven job scammers … Read More

Yes, another lovely day at work, other tens of emails to take care of, and, unfortunately, another set of emails coming from people having received “job offers” from Biotech Oil Nigeria. WOW! It seems the guys at Biotech Oil Nigeria are really full of “projects”. Unfortunately for them, long time ago Oil Offshore Marine has determined that they are job scammers, and we posted here information about them. Case Study follows: 1. If you didn’t know, Biotech Oil Nigeria is THE most powerful and the richest company in the world. Why? Read this: “2.1 BIOTECH OIL shall pay Employees on satisfactory performance of the services the sum USD 43,240 (Forty Three Thousand Two Hundred and Forty Dollars only) monthly or Euros equivalent depending on employee’s home country.” 2. Biotech Oil Nigeria offers employment without any formal interview, be it in person or by telephone. Now that’s really cool! 3. “Employer for each intercontinental trip s

Analisis de BIO 7 de Junio de 2007. Pincha en la imagen para ver el grafico ampliado. El 20 de Abril recomendabamos comprar Bio si superaba los 2,70 y vender si perdia los 2,30, y por el momento ni una cosa ni otra, lo que por otro lado es normal ya que hablabamos de un rango muy amplio. La cosa sigue mas o menos igual, nos movemos entre 2,65 y 2,35, con continuos bandazos, subidas muy fuertes

Cutting costs: A Michigan State University technician works with transgenic corn plants that could help lower the cost of making ethanol from plant stems and leaves. Credit: Mariam Sticklen, Michigan State University Cheaper, Cleaner Ethanol from Biotech CornThe genetically-modified plants break down their own cellulose, making it possible to use waste biomass to produce ethanol.Researchers have genetically engineered transgenic corn plants that produce enzymes that can turn their leaves and stems into sugar by breaking down cellulose. The plants could lower the cost of creating ethanol from these sources, making such biofuel more competitive with that produced from corn kernels, the primary source of ethanol in the United States today.Cellulosic sources of ethanol, such as waste biomass and switchgrass, are attractive because they are cheap and abundant. But converting cellulose, a complex carbohydrate, into sugars that can be fermented to make ethanol is more expensive than converti

I came across a great article over at Biotech Health Investor about the biotech short squeeze. A short squeeze is when a rapidly rising stock price escalates because short sellers need to buy stock back to cover their shorts. This causes the stock price to rise even higher. This happened very recently with Dendreon’s short squeeze following the good news about one of their primary drugs, Provenge. Prior to the approval, 30% of outstanding shares were shorted. After the initial good news, the stock gapped up from $5.22 to $12.93, and over the course of the next week reached a high of $25.25 from the resulting short squeeze. The article over at Biotech Health Investor looks at a few other biotech companies with upcoming decisions and a heavy short interest. Could be a good opportunity to cash in on a few short squeezes, if the news is good.

Mumbai: DuPont will set up plant biotech research centre at the company's proposed knowledge in Hyderabad, its first such facility outside the US. The $20-million knowledge center is part of the company's $100-million reinvestment plan and will focus on crop genetics to aid in the production of advanced seed products. DuPont currently has 20 crop genetics scientists working at a temporary facility near the planned site. The company expects the number of crop genetics scientists to grow to approximately 100 by year-end. "The global demand for agricultural crops is very strong. We have the science to help farmers and others across the value chain and this research centre is going to help us do that faster,'' said William Niebur, vice president, DuPont Crop Genetics Research and Development, in a release. Plant biotech scientists here will develop biotech traits and technologies that will be incorporated into multiple crops for markets the world over. The trait discov

Name: shivaMessage: im a student of final year bsc biotech i would like to know about the entrance exam conducted by anna university for msc biotech.i want to know about the syllabus and model question .how can i get this..... i expect your response... by shiva

Name: anjayMessage: i am presently undergoing bsc biotechnology 2nd year.i wanna know regarding summer training &regarding various entrance exams after bsc in biotech.pls do tell me regarding the min.qualifications.

As you may have noticed by now, my blog carries a new name, instead of Pinoy Explorer it now says BioTech Chronicles. Are you seeing things? Well no, I’m renaming this blog to the BioTech Chronciles for the following reasons of which I will explain to the fullest of my abilities. The name Pinoy Explorer, never rubbed off on me. It was fanciful but looking back at the past seven months of this blog’s existence, I’ve never really done justice to the name. I even consulted my non-blogging friends on this and they say the same thing. When they hear the name Pinoy Explorer before seeing the site, they have preconceptions that I have stories about my nature trips, expeditions, science experiments etc coupled with pictures there of. Sure those are preconceptions but I find myself in the same standing as my anonymous-non-commenting-non-blogging friends/readers. Though I’d love to live up to the name, as of now I’m unable to do so. I’m still stuck in the clas

Name: nehaMessage: how to get admission to biotech courses?What are colleges?Kindly provide complete information regarding colleges , admission process, fee structures, etc... I have passed class 12 this year'06 with bio-maths combination and secured 87% in aggregate